Werth V - Search Results

1

Current concepts and advances in dermatomyositis: a dermatological perspective.

Lim D, Fiorentino D, Werth V. Lim D, et al. Among authors: werth v. Clin Exp Rheumatol. 2023 Mar;41(2):359-369. doi: 10.55563/clinexprheumatol/ue71ku. Epub 2023 Jan 3. Clin Exp Rheumatol. 2023. PMID: 36622138 Free article. Review.

2

Skin involvement and outcome measures in systemic autoimmune diseases.

Albrecht J, Atzeni F, Baldini C, Bombardieri S, Dalakas MC, Demirkesen C, Yazici H, Mat C, Werth VP, Sarzi-Puttini P. Albrecht J, et al. Among authors: werth vp. Clin Exp Rheumatol. 2006 Jan-Feb;24(1 Suppl 40):S52-9. Clin Exp Rheumatol. 2006. PMID: 16466625 Review.

3

Management of cutaneous dermatomyositis: current therapeutic options.

Quain RD, Werth VP. Quain RD, et al. Am J Clin Dermatol. 2006;7(6):341-51. doi: 10.2165/00128071-200607060-00002. Am J Clin Dermatol. 2006. PMID: 17173468 Review.

4

Dermatomyositis.

Krathen MS, Fiorentino D, Werth VP. Krathen MS, et al. Among authors: werth vp. Curr Dir Autoimmun. 2008;10:313-32. doi: 10.1159/000131751. Curr Dir Autoimmun. 2008. PMID: 18460893 Free PMC article. Review.

5

Comparison of the reliability and validity of outcome instruments for cutaneous dermatomyositis.

Klein RQ, Bangert CA, Costner M, Connolly MK, Tanikawa A, Okawa J, Rose M, Fakharzadeh SS, Fiorentino D, Lee LA, Sontheimer RD, Taylor L, Troxel AB, Werth VP. Klein RQ, et al. Among authors: werth vp. Br J Dermatol. 2008 Sep;159(4):887-94. doi: 10.1111/j.1365-2133.2008.08711.x. Epub 2008 Jul 4. Br J Dermatol. 2008. PMID: 18616782 Free PMC article.

6

Modification of the cutaneous dermatomyositis disease area and severity index, an outcome instrument.

Yassaee M, Fiorentino D, Okawa J, Taylor L, Coley C, Troxel AB, Werth VP. Yassaee M, et al. Among authors: werth vp. Br J Dermatol. 2010 Mar;162(3):669-73. doi: 10.1111/j.1365-2133.2009.09521.x. Epub 2009 Oct 26. Br J Dermatol. 2010. PMID: 19863510 Free PMC article.

7

Dermatomyositis autoantibodies: clinical markers of patients past, present, and future.

Fiorentino D, Werth VP. Fiorentino D, et al. Arch Dermatol. 2011 Apr;147(4):492-4. doi: 10.1001/archdermatol.2011.41. Arch Dermatol. 2011. PMID: 21482900 No abstract available.

8

The importance of including amyopathic dermatomyositis in the idiopathic inflammatory myositis spectrum.

Ghazi E, Sontheimer RD, Werth VP. Ghazi E, et al. Clin Exp Rheumatol. 2013 Jan-Feb;31(1):128-34. Epub 2012 Nov 22. Clin Exp Rheumatol. 2013. PMID: 23190767 Free PMC article. Review.

9

Validation of the Cutaneous Dermatomyositis Disease Area and Severity Index: characterizing disease severity and assessing responsiveness to clinical change.

Anyanwu CO, Fiorentino DF, Chung L, Dzuong C, Wang Y, Okawa J, Carr K, Propert KJ, Werth VP. Anyanwu CO, et al. Among authors: werth vp. Br J Dermatol. 2015 Oct;173(4):969-74. doi: 10.1111/bjd.13915. Epub 2015 Aug 11. Br J Dermatol. 2015. PMID: 25994337 Free PMC article.

10

Practice and Educational Gaps in Lupus, Dermatomyositis, and Morphea.

Fett NM, Fiorentino D, Werth VP. Fett NM, et al. Dermatol Clin. 2016 Jul;34(3):243-50. doi: 10.1016/j.det.2016.02.006. Dermatol Clin. 2016. PMID: 27363879 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

464 results

Search Page